Association of C-reactive protein, interleukin-1 receptor antagonist and adiponectin with the metabolic syndrome (Q36419895)

14 August 2017

Association of C-reactive protein, interleukin-1 receptor antagonist and adiponectin with the metabolic syndrome (English)

1 reference

14 August 2017

1 reference

5

Markku Laakso

1 reference

14 August 2017

2

Mauno Vanhala

1 reference

14 August 2017

3

Hannu Kautiainen

1 reference

14 August 2017

1

Juha Saltevo

1 reference

14 August 2017

4

Esko Kumpusalo

1 reference

14 August 2017

1 January 2007

1 reference

Mediators of Inflammation

14 August 2017

1 reference

14 August 2017

2007

1 reference

14 August 2017

93573

1 reference

Creative Commons Attribution 3.0 Unported

14 August 2017

start time

1 January 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Metabolic syndrome and C-reactive protein in the general population: JMS Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222666

Fasting insulin, adiponectin, hs-CRP levels, and the components of metabolic syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222666

Adiponectin: a key adipocytokine in metabolic syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222666

The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222666

C-reactive protein, inflammation, and cardiovascular disease: clinical update

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222666

The metabolic syndrome--a new worldwide definition

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222666

Adipocytokines and metabolic syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222666

Adiponectin and adiponectin receptors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222666

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222666

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222666

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222666

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222666

Physiologic role of interleukin-1 receptor antagonist

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222666

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222666

Acute-phase proteins and other systemic responses to inflammation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222666

Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men.

30 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222666

30 September 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222666

The Measurement of Observer Agreement for Categorical Data

5 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222666

Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222666

Is type II diabetes mellitus a disease of the innate immune system?

28 June 2018

1 reference

https://api.crossref.org/works/10.1155%2F2007%2F93573

Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2007%2F93573

C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2007%2F93573

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2007%2F93573

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2007%2F93573

Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2007%2F93573

The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2007%2F93573

Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2007%2F93573

Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2007%2F93573

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2007%2F93573

Adiponectin independently predicts metabolic syndrome in overweight Latino youth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2007%2F93573

Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2007%2F93573

Adiponectin multimeric complexes and the metabolic syndrome trait cluster

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222666

C-Reactive Protein and Metabolic Syndrome in Elderly Women: A 12-year follow-up study

21 September 2018

1 reference

https://api.crossref.org/works/10.1155%2F2007%2F93573

Systemic Immune Mediators and Lifestyle Changes in the Prevention of Type 2 Diabetes: Results From the Finnish Diabetes Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2007%2F93573

Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men

21 January 2018

1 reference

12 December 2020

C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men: a population-based cohort study

1 reference

12 December 2020

High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes: a 7-year follow-up study

1 reference

12 December 2020

Low plasma adiponectin concentration is an indicator of the metabolic syndrome

1 reference

12 December 2020

Changes in Inflammatory Cytokines Are Related to Impaired Glucose Tolerance in Offspring of Type 2 Diabetic Subjects

1 reference

12 December 2020

Serum C-reactive protein levels correlates better to metabolic syndrome defined by International Diabetes Federation than by NCEP ATP III in men

1 reference

12 December 2020

Further inflammatory information on metabolic syndrome by adiponectin evaluation

1 reference

12 December 2020

Interleukin-1 receptor antagonist: a sensitive marker of instability in patients with coronary artery disease

1 reference

12 December 2020

Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management

1 reference

12 December 2020

Identifiers

DOI

10.1155/2007/93573

1 reference

14 August 2017

1 reference

PMC publication ID

2222666

14 August 2017

PubMed publication ID

18288276

1 reference

PMC publication ID

2222666